Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 4.215\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: CCOC(=O)N1CCC(NCCNC(=O)c2ccco2)CC1.O=C(O)C(=O)O
b: CCOC(=O)c1nsnc1NCCCl
c: COCCn1c(=O)[nH]c2cc(C(=O)NCCN3CCN(c4cccc(Cl)c4)CC3)ccc2c1=O
d: C=CCOc1ccc(/C=C/C(C)=N\O)cc1
e: COc1cc(NC(=O)COc2ccccc2Cl)ccc1NC(=O)C(C)C
Answer: d. C=CCOc1ccc(/C=C/C(C)=N\O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCOc1ccc(/C=C/C(C)=N\O)cc1
C=CCOc1ccc(/C=C/C(C)=N\O)cc1
(NZ)-N-[(E)-4-(4-prop-2-enoxyphenyl)but-3-en-2-ylidene]hydroxylamine